FDA Inspection 1280560 — Moti N. Ramgopal, M.D.
The FDA completed an inspection of Moti N. Ramgopal, M.D. on September 4, 2025 in Fort Pierce, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 4, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fort Pierce, FL (United States)